Figures & data
Figure 2. Schematic illustrations of the LF-ICS. (a) The structure of the LF-ICS, (b) The principle of the LF-ICS test for TMS.
![Figure 2. Schematic illustrations of the LF-ICS. (a) The structure of the LF-ICS, (b) The principle of the LF-ICS test for TMS.](/cms/asset/f33ca462-c58f-490b-bfa7-b252750fd397/cfai_a_1752155_f0002_oc.jpg)
Figure 3. Ultraviolet−visible absorption spectra of immunogen TMS-1-KLH (a) and coating antigen TMS-1-OVA (b).
![Figure 3. Ultraviolet−visible absorption spectra of immunogen TMS-1-KLH (a) and coating antigen TMS-1-OVA (b).](/cms/asset/798a45b7-4c47-4145-b8bf-d45ec7f0ae84/cfai_a_1752155_f0003_oc.jpg)
Figure 5. Optimization of the LF-ICS in 0.01 M PBS solution. The concentration of TMS-1-OVA (A) 0.3 mg/mL, (B) 0.8 mg/mL. The volume of K2CO3 (a) 8 μL, (b) 10 μL. The concentration of TMS standards: (1) 0 μg/mL, (2) 2.5 μg/mL.
![Figure 5. Optimization of the LF-ICS in 0.01 M PBS solution. The concentration of TMS-1-OVA (A) 0.3 mg/mL, (B) 0.8 mg/mL. The volume of K2CO3 (a) 8 μL, (b) 10 μL. The concentration of TMS standards: (1) 0 μg/mL, (2) 2.5 μg/mL.](/cms/asset/6b1eab65-16b0-4322-9275-1aeb5e52ad7e/cfai_a_1752155_f0005_oc.jpg)
Figure 6. The sensitivity analysis of the LF-ICS in 0.01 M PBS solution. The concentration of TMS standards: (1) 0 μg/mL, (2) 0.1 μg/mL, (3) 0.25 μg/mL, (4) 0.5 μg/mL, (5) 1 μg/mL, (6) 2.5 μg/mL, (7) 5 μg/mL.
![Figure 6. The sensitivity analysis of the LF-ICS in 0.01 M PBS solution. The concentration of TMS standards: (1) 0 μg/mL, (2) 0.1 μg/mL, (3) 0.25 μg/mL, (4) 0.5 μg/mL, (5) 1 μg/mL, (6) 2.5 μg/mL, (7) 5 μg/mL.](/cms/asset/8308c59c-b703-4ecb-b831-f19603ec393e/cfai_a_1752155_f0006_oc.jpg)